Predict your next investment

HEALTHCARE | Biotechnology
cariboubio.com

See what CB Insights has to offer

Founded Year

2011

Stage

IPO | IPO

Total Raised

$158.36M

Date of IPO

7/23/2021

Market Cap

1.32B

Stock Price

23.15

About Caribou Biosciences

Caribou Biosciences (NASDAQ:CRBU) is a developer of cellular engineering and analysis solutions based on CRISPR technologies, which provide enhanced capabilities to therapeutic development, agricultural biotechnology, industrial biotechnology, and basic and applied biological research.

Caribou Biosciences Headquarter Location

2929 7th Street Suite 105

Berkeley, California, 94710,

United States

510-982-6030

Latest Caribou Biosciences News

CRISPR Genomic Cure Market 2021- Growth, Trends Analysis Report 2031 | Future Market Insights

Oct 20, 2021

| Future Market Insights CRISPR Genomic Cure  market players – Intellia Therapeutics, Inc., Caribou Biosciences, Inc., CRISPR Therapeutics, Editas Medicine, Inc., Casebia Therapeutics, ERS Genomics, Toolgen Inc., Thermo Fisher Scientific, Inc, among others represent the global CRISPR Genomic Cure market. The market study depicts an extensive analysis of all the players running in the CRISPR Genomic Cure market report based on distribution channels, local network, innovative launches, industrial penetration, production methods, and revenue generation. Further, the market strategies and mergers & acquisitions associated with the players are enclosed in the CRISPR Genomic Cure market report. Future Market Insights, in its latest business report, elaborates on the current situation of the global CRISPR Genomic Cure market in terms of volume, value, production, and consumption. The report scrutinizes the market into various segments, end uses, regions, and players on the basis of demand patterns, and future prospects. Understanding the Impact of Covid-19 on Healthcare Industry With the pandemic plaguing maximum countries across the globe, healthcare industry is witnessing its fair share of ‘ups and downs’. The COVID-19 has placed an enormous strain on the healthcare sector’s workforce, facilities and infrastructure. Despite the endless pressure, healthcare sector is growing at a moderate pace due to the improvement in infrastructure and advancement in technology, healthcare sector is delivering a healthy performance. The FMI’s latest report on the CRISPR Genomic Cure market gives a detailed analysis on the impact of COVID-19 with an incisive coverage on the innovative strategies adopted by the market players to survive the challenges due to pandemic. Request For Table Of Content @  https://www.futuremarketinsights.com/toc/rep-gb-13911 Report Highlights: Critical Questions Answered in the Report What are ongoing trends that will shape market growth curve for global CRISPR Genomic Cure market? What are the drivers and challenges affecting the CRISPR Genomic Cure market demand? What are the recent technological advancement in the CRISPR Genomic Cure market? What are key trends and opportunities that will prevail the revenue growth of CRISPR Genomic Cure market players? How will evolving regulatory policies impact the market growth? What is the impact of Covid-19 on the CRISPR Genomic Cure market? Reasons to Buy the report We provide authentic and detailed an analysis on various market trends to enable businesses to make informed and beneficial decisions to attain competitive edge over key players. Our analysts provide detailed market segmentation along with meaningful insights and extensive reports that other companies fail to include. The report includes accurate analysis of the market and the current developing trends affecting the growth. FMI speaks to stakeholders across the spectrum, including C-level executives, distributors, product manufacturers, industry experts. This ensures that the data collected is from highly reliable sources. Why Future Market Insights? Detailed insights of market segments and sub-segments for historical as well as forecast period A competitive analysis of prominent players and emerging players in the CRISPR Genomic Cure market Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario About FMI Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers. Contact Jumeirah Lakes Towers, Dubai,

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Research containing Caribou Biosciences

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned Caribou Biosciences in 1 CB Insights research brief, most recently on Aug 31, 2021.

Article Thumbnail

Aug 31, 2021

What Is CRISPR?

Expert Collections containing Caribou Biosciences

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Caribou Biosciences is included in 6 Expert Collections, including Synthetic Biology.

S

Synthetic Biology

235 items

Companies involved in design and development of new biological parts, devices, and systems; as well as the re-design of existing biological systems.

P

Pharma Startups

6,549 items

Pharmaceutical companies working across drug discovery, drug development and drug manufacturing.

A

Animal Health Startups

193 items

Startups developing technology targeting health of livestock and aquaculture organisms

I

Industrial SynBio

67 items

Synthetic biology focused on replacing industrial and commercial materials.

B

Biopharmaceuticals

5,881 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

C

Cancer

3,605 items

Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.

Caribou Biosciences Patents

Caribou Biosciences has filed 67 patents.

The 3 most popular patent topics include:

  • Molecular biology
  • Biotechnology
  • Genetic engineering
patents chart

Application Date

Grant Date

Title

Related Topics

Status

2/21/2017

10/26/2021

Molecular biology, Biotechnology, Genetics, DNA, DNA repair

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

2/21/2017

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Grant Date

10/26/2021

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Related Topics

Molecular biology, Biotechnology, Genetics, DNA, DNA repair

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Caribou Biosciences Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Caribou Biosciences Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.